Company: LIDRW
Filing Date: 2025-08-15
Form Type: 424B3
Source: 0000947871-25-000783
Chunk: 12

Company: AEye, Inc.
Filing Date: 2025-08-15
Form: 424B3
Chunk 12
---
 12 for additional information. |
| Risk factors            | You should carefully read the “Risk Factors” beginning                                                                                                                                  
 on page 11 and the other information included or incorporated by reference in this prospectus for a discussion of factors you should consider                                           
 carefully before deciding to invest in our Common Stock.                                                                                                                                |
| Nasdaq symbol for our   
 Common Stock            | “LIDR.”                                                                                                                                                                                 |

Throughout this prospectus, when we refer to the shares of our Common Stock
being registered on behalf of the Selling Stockholder for offer and sale, we are referring to the shares of our Common Stock issuable
upon exercise of the Warrant. When we refer to the Selling Stockholder in this prospectus, we are referring to the selling stockholder
identified herein and, as applicable, its donees, pledgees, transferees or other successors-in-interest that may be identified in a supplement
to this prospectus or, if required, a post-effective amendment to the registration statement of which this prospectus is a part.

| 10 |

<div align='center'>RISK FACTORS</div>

An investment in the Common Stock involves
a high degree of risk. Before you decide to invest in shares of Common Stock, you should consider carefully all of the information in
this prospectus and the documents incorporated by reference herein and, in particular, the risks described below and the Risk Factors
included in any prospectus supplement or amendment, our Annual Report on Form 10-K for the year ended December 31, 2024, and any subsequently
filed Quarterly Reports on Form 10-Q and our other filings with the SEC, including our Current Reports on Form 8-K, that are incorporated
by reference herein and therein. The risks described in this prospectus or in any document incorporated by reference are not the only
ones we face. There may be other unknown or unpredictable economic, business, competitive, regulatory or other factors that could have
material adverse effects on our business, prospects, financial condition and results of operations. In any such case, the trading price
of shares of Common Stock could decline materially and you could lose all or part of your investment. Past financial performance may not
be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.

Future sales and issuances of our Common Stock or other securities might result in significant dilution and could cause the price of our Common Stock to decline.

To raise capital, we may sell our Common